EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.5.1.14 | Amniotic Band Syndrome |
30088852 |
A comprehensive clinical and genetic study in 127 patients with ID in Kinshasa, DR Congo. |
causal interaction
unassigned |
4
0 |
| 3.5.1.14 | Carcinogenesis |
33619241 |
Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor ? (TGF-?) Signaling Pathways. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
3
0 |
| 3.5.1.14 | Carcinoma |
2006156 |
Genetic relationship between acylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities. |
unassigned |
0 |
| 3.5.1.14 | Carcinoma |
7453852 |
Cobalt-activated acylase and aminoacylase I in human malignant tumors. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
2
4
0 |
| 3.5.1.14 | Carcinoma |
12693939 |
Probing the dimeric structure of porcine aminoacylase 1 by mass spectrometric and modeling procedures. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 3.5.1.14 | Carcinoma |
19028700 |
Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. |
ongoing research
unassigned |
3
0 |
| 3.5.1.14 | Carcinoma |
21128244 |
Differential aminoacylase expression in neuroblastoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
4
2 |
| 3.5.1.14 | Carcinoma |
34131440 |
Effect of the ACY-1 gene on HER2 and TRAIL expression in rectal carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
4
1 |
| 3.5.1.14 | Carcinoma, Hepatocellular |
24846301 |
Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
3
4
0 |
| 3.5.1.14 | Carcinoma, Hepatocellular |
29290764 |
Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
4 |
